Search results
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
Reuters via AOL· 5 days agoThe U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer...
Erasca restructures; Novartis moves to complete MorphoSys deal
BioPharma Dive via Yahoo Finance· 4 days agoThe cancer biotech is laying off one-fifth of its staff and scrapping three drugs. Elsewhere,...
US FDA approves expanded use of Bristol Myers' cancer cell therapy
Reuters· 5 days ago, opens new tab cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer...
123 New Jersey Students Graduate from Governor’s STEM Scholars
New Jersey Business Magazine· 6 days agoOn Saturday, May 11, 123 New Jersey high school and college students graduated from the Governor’s...
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
InvestorPlace· 5 days agoIt’s no secret that artificial intelligence (AI) promises to transform every industry and sector,...
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
AOL· 5 days agoThe Food and Drug Administration's decision marks the fourth approval for Breyanzi, which can now be used to treat follicular lymphoma patients who have received two or more prior lines of therapy ...
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
GenomeWeb News· 4 days agoOxford BioDynamics said Thursday that it is collaborating with King's College London to develop prognostic blood-based biomarkers to identify patients most likely to progress to rheumatoid arthritis ...
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 6 days agoUS pharmaceutical company Nabla Bio has secured $26m for generative protein design in a Series A financing round led by Radical Ventures. The round...
3 Attractive High Dividend Stocks Yielding Over 5%
TheStreet.com· 3 days agoAs a result, many stocks have lower dividend yields than they did several years ago, due to rising share prices. Truist Financial (TFC) is a financial...
Lantheus Holdings Names Jeffrey Humphrey to Be Medical Chief
Market Watch· 5 days agoBy Ben Glickman Lantheus Holdings named Jeffrey Humphrey as its next chief medical officer, effective May 28. The Bedford, Mass.-based company, which makes...